Literature DB >> 12054695

Identification of oxidized plasma proteins in Alzheimer's disease.

Joungil Choi1, Christina A Malakowsky, John M Talent, Craig C Conrad, Robert W Gracy.   

Abstract

The modification of proteins by reactive oxygen species is central to the pathology of Alzheimer's disease (AD). Previously, we have observed specific oxidized proteins in blood plasma of AD subjects [Biochem. Biophys. Res. Commun. 275 (2000) 678]. Plasma from AD subjects and age-matched controls was subjected to two-dimensional gel electrophoresis (2-DE). Oxidized proteins with new carbonyl groups were detected by reaction with 2,4-dinitrophenylhydrazine, followed by Western blotting with anti-DNP antibody. Seven principal oxidized protein spots (isoelectric point=4.7-5.5; molecular mass=45-65 kDa) were observed, with varying levels of oxidation in plasma samples from both AD and non-AD subjects. Matrix-assisted laser desorption mass spectroscopy (MALDI-TOF/MS) revealed that these oxidized proteins were isoforms of fibrinogen gamma-chain precursor protein and of alpha-1-antitrypsin precursor. These proteins exhibited a two- to sixfold greater specific oxidation index in plasma from AD subjects when compared to controls. Both these proteins have been previously implicated in the pathology of the disease. It is possible that oxidized isoforms of these proteins may serve as biomarkers for AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054695     DOI: 10.1016/S0006-291X(02)00420-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysis.

Authors:  Cheng Zhang; Ching-Chang Kuo; Alan W L Chiu; June Feng
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid.

Authors:  K Nagai; T Betsuyaku; T Kondo; Y Nasuhara; M Nishimura
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

Review 3.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

4.  Problems associated with biological markers of Alzheimer's disease.

Authors:  H J Frey; K M Mattila; M A Korolainen; T Pirttilä
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 5.  Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.

Authors:  Leila H Choe; Brenda G Werner; Kelvin H Lee
Journal:  NeuroRx       Date:  2006-07

6.  Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.

Authors:  Lei Zhao; Joel N Buxbaum; Natàlia Reixach
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

Review 7.  Diabetes and Cognitive Impairment.

Authors:  Lindsay A Zilliox; Krish Chadrasekaran; Justin Y Kwan; James W Russell
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

Review 8.  Blood-based biomarkers of Alzheimer's disease: challenging but feasible.

Authors:  Madhav Thambisetty; Simon Lovestone
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 9.  Clinical diagnosis for discogenic low back pain.

Authors:  Yin-gang Zhang; Tuan-mao Guo; Xiong Guo; Shi-xun Wu
Journal:  Int J Biol Sci       Date:  2009-10-13       Impact factor: 6.580

Review 10.  Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

Authors:  Yongyao Fu; Deming Zhao; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2014-06-25       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.